Skip to main content

Additionally, over the last several years, our work has expanded regarding clinical and translational research activities. Currently, we have several ongoing IRB approved research projects.

Below are studies where our lab is the principal investigator or site lead investigator for the following studies:

  • IRB 20-2600 Collection of clinical excess of blood samples from COVID-19 patients to evaluate the biological responses before and after dexamethasone. The COVIDEX Study
  • IRB 20-2085 A phase I double-blinded randomized, placebo-controlled safety and early efficacy trial of cryopreserved cord blood-derived T-regulatory cells infusions (CK0802) in the treatment of COVID-19 induced acute respiratory distress syndrome. The RESOLVE Study
  • IRB 20-1394 Prone position and respiratory outcomes in non-intubated COVID patients. The PRONE Study
  • IRB 17-1670 Alveolar Kinetics in Acute Respiratory Distress Syndrome. The AKA Study